News

bit.bio’s Founder and CEO Dr Mark Kotter on creating every cell type and kickstarting a cell therapy revolution.

Mark Kotter talks about the benefits of human cells for researchers, and how they can shape the future of drug development.

bit.bio CEO Dr Mark Kotter interviewed by Fiona Mischel on the Built with Biology Podcast.

They ask about reprogramming cells and how the company is aiming to develop cell therapies.

Founder and CEO Mark Kotter talks to Eva (The Naked Scientist podcast) about all things cell reprogramming.

Episode 3 of our special three part mini-series.

The conversation covers our opti-ox technology and its potential for cell therapies.

The conversation covers the promise of reprogrammed human cells for therapies and drug discovery.